HE HEALTH EFFECTS OF CANNABIS AND CANNABINOIDS January 2017 THE CURRENT STATE OF EVIDENCE AND RECOMMENDATIONS FOR RESEARCH

This is cherry picking beyond belief. Since you can't legally study marijuana effects there will be no positive evidence and drug companies will obfuscate and confuse the general public so as to not lower their profits. You are completely on your own, probably have to move to a legal state or travel there regularly. Don't listen to me, with no medical background everything I say can be easily dismissed by so-called experts. Lots more followup needed which will never occur with our fucking failures of stroke associations.

My 13 reasons for marijuana use post-stroke.  

But don't listen to me, I have absolutely no medical training, you don't need medical training to read and understand research or its' good points on your own.

THE HEALTH EFFECTS OF CANNABIS AND CANNABINOIDS January 2017 THE CURRENT STATE OF EVIDENCE AND  RECOMMENDATIONS FOR RESEARCH

We are interested in the items I've bolded.

To read the full report, please visit

nationalacademies.org/CannabisHealthEffects.

CONCLUSIONS FOR: THERAPEUTIC EFFECTS

There is conclusive or substantial evidence that cannabis or cannabinoids are effective:

• For the treatment for chronic pain in adults (cannabis) (4-1)

• Antiemetics in the treatment of chemotherapy-induced nausea and vomiting (oral cannabinoids) (4-3)

• For improving patient-reported multiple sclerosis spasticity symptoms (oral cannabinoids) (4-7a)

There is moderate evidence that cannabis or cannabinoids are effective for:

• Improving short-term sleep outcomes in individuals with sleep disturbance associated with obstructive sleep apnea

syndrome, fibromyalgia, chronic pain, and multiple sclerosis (cannabinoids, primarily nabiximols) (4-19)

There is limited evidence that cannabis or cannabinoids are effective for:

• Increasing appetite and decreasing weight loss associated with HIV/AIDS (cannabis and oral cannabinoids) (4-4a)

• Improving clinician-measured multiple sclerosis spasticity symptoms (oral cannabinoids) (4-7a)

• Improving symptoms of Tourette syndrome (THC capsules) (4-8)

• Improving anxiety symptoms, as assessed by a public speaking test, in individuals with social anxiety disorders (cannabidiol)

(4-17)

• Improving symptoms of posttraumatic stress disorder (nabilone; one single, small fair-quality trial) (4-20)

There is limited evidence of a statistical association between cannabinoids and:

• Better outcomes (i.e., mortality, disability) after a traumatic brain injury or intracranial hemorrhage (4-15)

There is limited evidence that cannabis or cannabinoids are ineffective

for:

• Improving symptoms associated with dementia (cannabinoids) (4-13)

• Improving intraocular pressure associated with glaucoma (cannabinoids) (4-14)

• Reducing depressive symptoms in individuals with chronic pain or multiple sclerosis (nabiximols, dronabinol, and nabilone)

(4-18)